Interaction between KDELR2 and HSP47 as a Key Determinant in Osteogenesis Imperfecta Caused by Bi-allelic Variants in KDELR2.
Adult
Alleles
Amino Acid Sequence
Animals
Binding Sites
Bone and Bones
/ metabolism
Chickens
Child, Preschool
Collagen Type I
/ chemistry
Endoplasmic Reticulum
/ metabolism
Female
Fibroblasts
/ metabolism
Gene Expression
Golgi Apparatus
/ metabolism
HSP47 Heat-Shock Proteins
/ chemistry
Humans
Infant
Male
Osteogenesis Imperfecta
/ diagnosis
Pedigree
Primary Cell Culture
Protein Binding
Protein Interaction Domains and Motifs
Protein Structure, Secondary
Protein Transport
Sequence Alignment
Sequence Homology, Amino Acid
Vesicular Transport Proteins
/ chemistry
HSP47
KDELR2
osteogenesis imperfecta
retrograde Golgi-ER transport
Journal
American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475
Informations de publication
Date de publication:
05 11 2020
05 11 2020
Historique:
received:
15
02
2020
accepted:
22
09
2020
pubmed:
15
10
2020
medline:
15
12
2020
entrez:
14
10
2020
Statut:
ppublish
Résumé
Osteogenesis imperfecta (OI) is characterized primarily by susceptibility to fractures with or without bone deformation. OI is genetically heterogeneous: over 20 genetic causes are recognized. We identified bi-allelic pathogenic KDELR2 variants as a cause of OI in four families. KDELR2 encodes KDEL endoplasmic reticulum protein retention receptor 2, which recycles ER-resident proteins with a KDEL-like peptide from the cis-Golgi to the ER through COPI retrograde transport. Analysis of patient primary fibroblasts showed intracellular decrease of HSP47 and FKBP65 along with reduced procollagen type I in culture media. Electron microscopy identified an abnormal quality of secreted collagen fibrils with increased amount of HSP47 bound to monomeric and multimeric collagen molecules. Mapping the identified KDELR2 variants onto the crystal structure of G. gallus KDELR2 indicated that these lead to an inactive receptor resulting in impaired KDELR2-mediated Golgi-ER transport. Therefore, in KDELR2-deficient individuals, OI most likely occurs because of the inability of HSP47 to bind KDELR2 and dissociate from collagen type I. Instead, HSP47 remains bound to collagen molecules extracellularly, disrupting fiber formation. This highlights the importance of intracellular recycling of ER-resident molecular chaperones for collagen type I and bone metabolism and a crucial role of HSP47 in the KDELR2-associated pathogenic mechanism leading to OI.
Identifiants
pubmed: 33053334
pii: S0002-9297(20)30329-3
doi: 10.1016/j.ajhg.2020.09.009
pmc: PMC7675035
pii:
doi:
Substances chimiques
Collagen Type I
0
HSP47 Heat-Shock Proteins
0
SERPINH1 protein, human
0
Vesicular Transport Proteins
0
KDELR2 protein, human
147097-18-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
989-999Informations de copyright
Copyright © 2020. Published by Elsevier Inc.
Références
Oncotarget. 2015 Feb 20;6(5):3375-93
pubmed: 25682866
Am J Hum Genet. 2009 Oct;85(4):521-7
pubmed: 19781681
Cell Cycle. 2007 Jul 15;6(14):1675-81
pubmed: 17630507
J Biol Chem. 2017 Oct 20;292(42):17216-17224
pubmed: 28860186
Int J Mol Sci. 2019 Nov 09;20(22):
pubmed: 31717602
FEBS J. 2019 Aug;286(15):3033-3056
pubmed: 31220415
Bone. 2006 Oct;39(4):901-6
pubmed: 16730480
J Biol Chem. 2016 Jun 10;291(24):12612-26
pubmed: 27129216
Transl Res. 2017 Mar;181:27-48
pubmed: 27914223
J Cell Biol. 2007 Dec 17;179(6):1193-204
pubmed: 18086916
Trends Biochem Sci. 2016 Feb;41(2):118-119
pubmed: 26749089
J Biol Chem. 2019 Feb 8;294(6):2133-2141
pubmed: 30541925
Cell. 1989 Mar 10;56(5):801-13
pubmed: 2647301
Am J Med Genet A. 2014 Jun;164A(6):1470-81
pubmed: 24715559
Am J Hum Genet. 2015 Mar 5;96(3):432-9
pubmed: 25683121
FEBS Lett. 2009 Dec 3;583(23):3863-71
pubmed: 19854180
Science. 2019 Mar 8;363(6431):1103-1107
pubmed: 30846601
Mol Genet Genomic Med. 2018 Jan;6(1):15-26
pubmed: 29150909
FASEB J. 2020 Jul 27;:
pubmed: 32716577
Am J Hum Genet. 2010 Mar 12;86(3):389-98
pubmed: 20188343
Hum Mol Genet. 2015 Apr 1;24(7):1918-28
pubmed: 25510505
Nat Cell Biol. 2008 Aug;10(8):912-22
pubmed: 18641641
Hum Mol Genet. 2013 Jan 1;22(1):1-17
pubmed: 22949511
Methods Enzymol. 1987;145:3-78
pubmed: 3600396
Lancet. 2016 Apr 16;387(10028):1657-71
pubmed: 26542481